S. Brook

1.8k total citations
38 papers, 1.4k citations indexed

About

S. Brook is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Clinical Psychology. According to data from OpenAlex, S. Brook has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Psychiatry and Mental health, 11 papers in Pediatrics, Perinatology and Child Health and 11 papers in Clinical Psychology. Recurrent topics in S. Brook's work include Schizophrenia research and treatment (22 papers), Bipolar Disorder and Treatment (16 papers) and Epilepsy research and treatment (9 papers). S. Brook is often cited by papers focused on Schizophrenia research and treatment (22 papers), Bipolar Disorder and Treatment (16 papers) and Epilepsy research and treatment (9 papers). S. Brook collaborates with scholars based in South Africa, United States and United Kingdom. S. Brook's co-authors include Michael Berk, James V. Lucey, Martín Dossenbach, Alan Breier, Martin Birkett, Pádraig Wright, S.R. David, Karena Meehan, Cindy C. Taylor and R. Palmer and has published in prestigious journals such as Psychopharmacology, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

S. Brook

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Brook South Africa	17	1.2k	422	190	151	91	38	1.4k
Fred Grossman United States	12	1.3k 1.1×	163 0.4×	237 1.2×	189 1.3×	43 0.5×	17	1.7k
Stuart Kushner United States	14	1.0k 0.9×	250 0.6×	208 1.1×	119 0.8×	41 0.5×	19	1.2k
John Cookson United Kingdom	19	772 0.6×	99 0.2×	253 1.3×	138 0.9×	106 1.2×	62	1.1k
Mauricio Tohen United States	8	1.1k 0.9×	285 0.7×	144 0.8×	119 0.8×	23 0.3×	9	1.2k
Ludmila Kryzhanovskaya United States	17	830 0.7×	255 0.6×	149 0.8×	87 0.6×	149 1.6×	29	1.1k
Wayne Macfadden United States	20	1.5k 1.3×	188 0.4×	113 0.6×	488 3.2×	101 1.1×	43	2.2k
Starr L. Grundy United States	12	820 0.7×	141 0.3×	97 0.5×	127 0.8×	37 0.4×	17	994
J. Tegeler Germany	15	817 0.7×	289 0.7×	92 0.5×	126 0.8×	25 0.3×	41	929
Seema Quraishi United Kingdom	14	1.0k 0.9×	239 0.6×	112 0.6×	98 0.6×	48 0.5×	20	1.2k
Dan Zimbroff United States	12	890 0.7×	317 0.8×	117 0.6×	266 1.8×	198 2.2×	21	1.3k

Countries citing papers authored by S. Brook

Since Specialization

Citations

This map shows the geographic impact of S. Brook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Brook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Brook more than expected).

Fields of papers citing papers by S. Brook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Brook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Brook. The network helps show where S. Brook may publish in the future.

Co-authorship network of co-authors of S. Brook

This figure shows the co-authorship network connecting the top 25 collaborators of S. Brook. A scholar is included among the top collaborators of S. Brook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Brook. S. Brook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alptekın, Köksal, et al.. (2009). Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. International Clinical Psychopharmacology. 24(5). 229–238. 36 indexed citations

Citrome, Leslie, Jan Volavka, Pál Czobor, et al.. (2006). Efficacy of Ziprasidone Against Hostility in Schizophrenia. The Journal of Clinical Psychiatry. 67(4). 638–642. 30 indexed citations

Brook, S., et al.. (2005). Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology. 178(4). 514–523. 47 indexed citations

Bitter, István, Martín Dossenbach, S. Brook, et al.. (2003). Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(1). 173–180. 98 indexed citations

Breier, Alan, Karena Meehan, Martin Birkett, et al.. (2002). A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia. Archives of General Psychiatry. 59(5). 441–441. 207 indexed citations

Zimbroff, Dan, S. Brook, & I. Benattia. (2002). Safety and tolerability of IM ziprasidone: Review of clinical trial data. European Neuropsychopharmacology. 12. 294–294. 1 indexed citations

Berk, Michael, et al.. (2001). Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. International Clinical Psychopharmacology. 16(2). 87–92. 66 indexed citations

Emsley, Robin, S. Brook, Sophia Frangou, et al.. (2001). Safety and tolerability of lamotrigine in controlled mood disorder trials. European Neuropsychopharmacology. 11. S204–S205. 3 indexed citations

Berk, Michael, et al.. (2000). Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial.. Annals of Clinical Psychiatry. 12(1). 5–10. 91 indexed citations

10.

Brook, S.. (2000). A pilot study of intramuscular ziprasidone in the short-term treatment of patients with acute exacerbation of schizophrenia. Human Psychopharmacology Clinical and Experimental. 15(7). 521–524. 12 indexed citations

11.

Brook, S., et al.. (2000). Intramuscular Ziprasidone Compared With Intramuscular Haloperidol in the Treatment of Acute Psychosis. The Journal of Clinical Psychiatry. 61(12). 933–941. 111 indexed citations

12.

Lucey, James V., S. Brook, D.G. Daniel, Karen R. Reeves, & Edmund P. Harrigan. (2000). Intramuscular (IM) ziprasidone: A novel treatment for the short-term management of agitated psychotic patients. Schizophrenia Research. 41(1). 208–208. 5 indexed citations

13.

Berk, Michael, et al.. (1999). Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. International Clinical Psychopharmacology. 14(6). 339–343. 133 indexed citations

14.

Brook, S., et al.. (1998). A prospective randomised double-blind controlled study of the efficacy of lorazepam versus clothiapine in the control of acutely behaviourally disturbed patients. Deakin Research Online (Deakin University). 88(3). 307–310. 9 indexed citations

15.

Brook, S., et al.. (1998). A randomized controlled double blind study of zuclopenthixol acetate compared to haloperidol in acute psychosis. Human Psychopharmacology Clinical and Experimental. 13(1). 17–20. 14 indexed citations

16.

Brook, S., et al.. (1998). Intramuscular (IM) ziprasidone vs. IM haloperidol in patients with acute, non-organic psychosis. European Psychiatry. 13(S4). 303s–303s. 5 indexed citations

17.

Berk, Michael, et al.. (1996). Superiorlty of lithium over verapamil in mania: A randomized controlled trial. European Neuropsychopharmacology. 6. 9–10. 1 indexed citations

18.

Berk, Michael, et al.. (1996). Superiority of Lithium Over Verapamil in Mania. The Journal of Clinical Psychiatry. 57(11). 543–546. 39 indexed citations

19.

Sarne, Yosef, et al.. (1995). Imipramine Binding to Blood Platelets and Aggressive Behavior in Offenders, Schizophrenics and Normal Volunteers. Neuropsychobiology. 31(3). 120–124. 17 indexed citations

20.

Brook, S., et al.. (1984). A prospective randomized trial of adenoidectomy vs grommet insertion in the treatment of glue ear. Clinical Otolaryngology. 9(2). 67–75. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact